1. Home
  2. GSK vs BX Comparison

GSK vs BX Comparison

Compare GSK & BX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GSK plc (Each representing two)

GSK

GSK plc (Each representing two)

HOLD

Current Price

$56.52

Market Cap

96.1B

Sector

Health Care

ML Signal

HOLD

Logo Blackstone Inc.

BX

Blackstone Inc.

HOLD

Current Price

$113.66

Market Cap

116.4B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSK
BX
Founded
1715
1985
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
96.1B
116.4B
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
GSK
BX
Price
$56.52
$113.66
Analyst Decision
Buy
Buy
Analyst Count
2
16
Target Price
N/A
$169.50
AVG Volume (30 Days)
6.0M
8.9M
Earning Date
01-01-0001
04-30-2026
Dividend Yield
3.07%
4.27%
EPS Growth
N/A
6.91
EPS
N/A
3.87
Revenue
N/A
$14,450,265,000.00
Revenue This Year
$6.75
$14.94
Revenue Next Year
$4.88
$21.75
P/E Ratio
$32.75
$28.77
Revenue Growth
N/A
9.22
52 Week Low
$32.38
$105.09
52 Week High
$61.70
$190.09

Technical Indicators

Market Signals
Indicator
GSK
BX
Relative Strength Index (RSI) 48.21 31.52
Support Level $47.89 N/A
Resistance Level $60.37 $146.80
Average True Range (ATR) 0.79 5.34
MACD -0.67 -0.52
Stochastic Oscillator 4.34 27.10

Price Performance

Historical Comparison
GSK
BX

About GSK GSK plc (Each representing two)

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

About BX Blackstone Inc.

Blackstone is the world's largest alternative-asset manager with $1.242 trillion in total asset under management, including $906.2 billion in fee-earning assets under management, at the end of September 2025. The company operates with scale in each of its major product lines: private equity (26% of fee-earning AUM and 33% of base management fees), real estate/real assets (31% and 35%), private credit (34% and 25%), and other alternatives (9% and 7%). While the firm primarily serves institutional investors (84% of AUM), it also caters to clients in the high-net-worth channel (16%). Blackstone operates through 25 offices in the Americas (8), Europe and the Middle East (9), and the Asia-Pacific region (8).

Share on Social Networks: